Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN106946704A reveals efficient catalyst-free Wittig route for fused aromatics. Enables cost reduction in fine chemical manufacturing and scalable supply.
Novel Pd-catalyzed cyclization of anilines and alkynes offers high-purity beta-halopyrroles with simplified supply chains and reduced manufacturing costs.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Patent CN110041235B reveals a novel NTFTS reagent for synthesizing trifluoroacetophenones. Discover cost-effective, mild conditions for API manufacturing.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yield, broad scope, cost-effective for pharma intermediates.
Patent CN111978265B reveals a robust FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112812032B reveals a green Rh-catalyzed route using DMC. Offers cost-effective, scalable production of high-purity acetamide intermediates.
Patent CN113214199B reveals a novel acid-catalyzed rearrangement for benzofuran derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111423381A details a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective API intermediate manufacturing solutions.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for quinazolinones, offering significant supply chain advantages for pharmaceutical manufacturing.
Novel nickel-catalyzed synthesis reduces costs and improves supply chain reliability for high-purity alpha beta-unsaturated thioester pharmaceutical intermediates manufacturing.
Patent CN107382899B reveals a mild, one-pot synthesis for 2-hydroxy-1,4-benzoxazine derivatives, offering high yields and simplified supply chains for API manufacturing.
Novel silver oxide promoted method for 5-trifluoromethyl imidazoles. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Novel nickel-catalyzed method for ketone nitrile compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing significantly
Patent CN113121462A discloses a metal-free synthesis of 5-CF3 triazoles. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering scalable supply chain solutions and cost efficiency.
Novel AlCl3-catalyzed route offers high stereoselectivity and mild conditions for scalable production of key pharmaceutical intermediates.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and simplified operations for API manufacturing.